119 related articles for article (PubMed ID: 29658585)
1. Inhibitors of heat shock protein 90 augment endothelin‑1‑induced heat shock protein 27 through the SAPK/JNK signaling pathway in osteoblasts.
Fujita K; Otsuka T; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Mol Med Rep; 2018 Jun; 17(6):8542-8547. PubMed ID: 29658585
[TBL] [Abstract][Full Text] [Related]
2. Enhancement by HSP90 inhibitor of PGD2-stimulated HSP27 induction in osteoblasts: Suppression of SAPK/JNK and p38 MAP kinase.
Kim W; Tokuda H; Kawabata T; Fujita K; Sakai G; Nakashima D; Tachi J; Kuroyanagi G; Matsushima-Nishiwaki R; Tanabe K; Otsuka T; Iida H; Kozawa O
Prostaglandins Other Lipid Mediat; 2019 Aug; 143():106327. PubMed ID: 30946899
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of TGF-β-induced HSP27 by HSP90 inhibitors in osteoblasts.
Kuroyanagi G; Tokuda H; Fujita K; Kawabata T; Sakai G; Kim W; Hioki T; Tachi J; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
BMC Musculoskelet Disord; 2022 May; 23(1):495. PubMed ID: 35619094
[TBL] [Abstract][Full Text] [Related]
4. HSP90 inhibitors strengthen extracellular ATP-stimulated synthesis of interleukin-6 in osteoblasts: Amplification of p38 MAP kinase.
Hioki T; Tokuda H; Nakashima D; Fujita K; Kawabata T; Sakai G; Kim W; Tachi J; Tanabe K; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
Cell Biochem Funct; 2021 Jan; 39(1):88-97. PubMed ID: 32567086
[TBL] [Abstract][Full Text] [Related]
5. HSP90 inhibitors potentiate PGF2α-induced IL-6 synthesis via p38 MAP kinase in osteoblasts.
Fujita K; Tokuda H; Kuroyanagi G; Yamamoto N; Kainuma S; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
PLoS One; 2017; 12(5):e0177878. PubMed ID: 28542188
[TBL] [Abstract][Full Text] [Related]
6. Involvement of stress-activated protein kinase/c-Jun N-terminal kinase in endothelin-1-induced heat shock protein 27 in osteoblasts.
Tokuda H; Niwa M; Ito H; Oiso Y; Kato K; Kozawa O
Eur J Endocrinol; 2003 Sep; 149(3):239-45. PubMed ID: 12943527
[TBL] [Abstract][Full Text] [Related]
7. HSP90 inhibitors diminish PDGF-BB-induced migration of osteoblasts via suppression of p44/p42 MAP kinase.
Kawabata T; Tokuda H; Fujita K; Matsushima-Nishiwaki R; Sakai G; Tachi J; Hioki T; Kim W; Iida H; Otsuka T; Kozawa O
Biomed Res; 2019; 40(4):169-178. PubMed ID: 31413238
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Hayashi K; Takai S; Matsushima-Nishiwaki R; Hanai Y; Kato K; Tokuda H; Kozawa O
Life Sci; 2008 May; 82(19-20):1012-7. PubMed ID: 18407296
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 27 (HSPB1) suppresses the PDGF-BB-induced migration of osteoblasts.
Kainuma S; Tokuda H; Yamamoto N; Kuroyanagi G; Fujita K; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
Int J Mol Med; 2017 Oct; 40(4):1057-1066. PubMed ID: 28902366
[TBL] [Abstract][Full Text] [Related]
10. Involvement of stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) in prostaglandin F2alpha-induced heat shock protein 27 in osteoblasts.
Tokuda H; Niwa M; Ishisaki A; Nakajima K; Ito H; Kato K; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):441-7. PubMed ID: 15062846
[TBL] [Abstract][Full Text] [Related]
11. Unphosphorylated heat shock protein 27 suppresses fibroblast growth factor‑2‑stimulated vascular endothelial growth factor release in osteoblasts.
Kondo A; Tokuda H; Matsushima-Nishiwaki R; Kato K; Kuroyanagi G; Mizutani J; Fukuoka M; Wada I; Kozawa O; Otsuka T
Mol Med Rep; 2013 Aug; 8(2):691-5. PubMed ID: 23783659
[TBL] [Abstract][Full Text] [Related]
12. Suppression by HSP90 inhibitors of BMP‑4‑stimulated osteoprotegerin synthesis in osteoblasts: Attenuation of p70 S6 kinase.
Kawabata T; Otsuka T; Fujita K; Kainuma S; Yamamoto N; Kuroyanagi G; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Mol Med Rep; 2017 Dec; 16(6):8507-8512. PubMed ID: 28983611
[TBL] [Abstract][Full Text] [Related]
13. Attenuation by HSP90 inhibitors of EGF-elicited migration of osteoblasts: involvement of p44/p42 MAP kinase.
Kuroyanagi G; Kawabata T; Tokuda H; Fujita K; Matsushima-Nishiwaki R; Sakai G; Tachi J; Hioki T; Kim W; Iida H; Otsuka T; Kozawa O
Connect Tissue Res; 2022 Jul; 63(4):359-369. PubMed ID: 34100663
[TBL] [Abstract][Full Text] [Related]
14. Specific induction of heat shock protein 27 by glucocorticoid in osteoblasts.
Kozawa O; Niwa M; Hatakeyama D; Tokuda H; Oiso Y; Matsuno H; Kato K; Uematsu T
J Cell Biochem; 2002; 86(2):357-64. PubMed ID: 12112005
[TBL] [Abstract][Full Text] [Related]
15. HSP90 limits thrombin‑stimulated IL‑6 synthesis in osteoblast‑like MC3T3‑E1 cells: Regulation of p38 MAPK.
Fujita K; Otsuka T; Kawabata T; Kainuma S; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Int J Mol Med; 2018 Oct; 42(4):2185-2192. PubMed ID: 30066835
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin D2 induces the phosphorylation of HSP27 in osteoblasts: function of the MAP kinase superfamily.
Takai S; Tokuda H; Yoshida M; Yasuda E; Matsushima-Nishiwaki R; Harada A; Kato K; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):61-7. PubMed ID: 16876988
[TBL] [Abstract][Full Text] [Related]
17. (-)-epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts.
Yamauchi J; Takai S; Matsushima-Nishiwaki R; Hanai Y; Doi T; Kato H; Ogura S; Kato K; Tokuda H; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):173-9. PubMed ID: 17949962
[TBL] [Abstract][Full Text] [Related]
18. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate enhances prostaglandin D2-stimulated heat shock protein 27 induction in osteoblasts.
Yoshida M; Niwa M; Ishisaki A; Hirade K; Ito H; Shimizu K; Kato K; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2004 Dec; 71(6):351-62. PubMed ID: 15519494
[TBL] [Abstract][Full Text] [Related]
20. Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts.
Kuroyanagi G; Mizutani J; Kondo A; Yamamoto N; Matsushima-Nishiwaki R; Otsuka T; Kozawa O; Tokuda H
Prostaglandins Leukot Essent Fatty Acids; 2014 Sep; 91(3):73-80. PubMed ID: 24813642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
